Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder
Bibliographic Data
| ID | 4662014 |
|---|---|
| Authors | Ben Sessa (0000-0002-1212-6060, Imperial College London, corresponding author) |
| Year | 2017 |
| Volume | 1 |
| Issue | 1 |
| Pages | 1-9 |
| Publication date | 2017-04-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Psychedelic Studies (JOURNAL) |
| Journal identifiers | ISSN: 2559-9283 • E-ISSN: 2559-9283 |
| Publisher | Akademiai Kiado Zrt (PUBLISHER) |
| DOI | 10.1556/2054.01.2016.003 |
| OpenAlex | W2592637059 |
| Language | EN |
| References cited | 63 |
Treating people with alcohol use disorder has been an important target area for psychedelic research – both in the first studies of the 1950s and during the Psychedelic Renaissance of the last 10 years. To date, most studies have looked at the classical psychedelic drugs as adjuncts to psychotherapy; with attention paid to the psychospiritual aspect of the experience as a central therapeutic process in effecting abstinence from drinking. Psychotherapy assisted with 3,4,-methylenedioxymethamphetamine (MDMA) has never been explored for treating alcohol use disorder. However, MDMA has some unique pharmacological characteristics – particularly its capacity for reducing the fear response and facilitating engagement in therapy around past psychological trauma – that could make it a useful candidate for tackling the core features of alcohol use disorder. This paper briefly describes the burden of alcohol use disorders and the history of psychedelic-assisted psychotherapy in the field of addictions. It gives the theoretical and experimental justification for MDMA-assisted psychotherapy for treating people with alcohol use disorder and introduces a forthcoming study from Bristol and London, UK, exploring the role for MDMA in treating a person with this challenging condition
Abstinence · Addiction · Alcohol · Alcohol use disorder · MDMA · Psychiatry · Psychotherapist · Clinical Psychology · Forensic Toxicology and Drug Analysis · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Lysergic acid diethylamide (LSD) for alcoholism
Ayahuasca-Assisted Therapy for Addiction
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder
Psilocybin-assisted treatment for alcohol dependence
The Pittsburgh sleep quality index
Use of d -Lysergic Acid Diethylamide in the Treatment of Alcoholism
Ketamine Psychedelic Therapy (KPT)
New Age Seekers
Subjective Reports of the Effects of MDMA in a Clinical Setting
The benefits of being present
Disclosure of traumas and psychosomatic processes
| Citation velocity | historical |
|---|---|
| Highly cited | No |